Arin Nam
Impact in
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
-
- MicroRNA in disease regulation
Papers in
-
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 3
- Angiogenesis and VEGF in Cancer 2
- Oncology 9
- Lung Cancer Research Studies 2
- Co-authors
- Ravi Salgia (19 shared papers)Rebecca Pharaon (7 shared papers)Isa Mambetsariev (11 shared papers)Atish Mohanty (9 shared papers)Martin Sattler (4 shared papers)Prakash Kulkarni (6 shared papers)Erminia Massarelli (8 shared papers)Saumya Srivastava (6 shared papers)
- Journals
- iScience (3 papers)Journal of Clinical Medicine (3 papers)Oncotarget (2 papers)Cancer Research (2 papers)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Arin Nam
22 papers receiving 457 citations
Peers
Comparison fields: 5 of 65
- Immunology and Allergy 46
- Cancer Research 102
- Oncology 134
- Molecular Biology 253
- Pulmonary and Respiratory Medicine 94
Countries citing papers authored by Arin Nam
This map shows the geographic impact of Arin Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arin Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arin Nam more than expected).
Fields of papers citing papers by Arin Nam
This network shows the impact of papers produced by Arin Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arin Nam. The network helps show where Arin Nam may publish in the future.
Co-authors
The 25 scholars most cited alongside Arin Nam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 105 | |
| 2 | 2020 | 78 | |
| 3 | 2022 | 45 | |
| 4 | 2018 | 37 | |
| 5 | 2019 | 33 | |
| 6 | 2020 | 32 | |
| 7 | 2020 | 22 | |
| 8 | 2023 | 17 | |
| 9 | 2021 | 15 | |
| 10 | 2023 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2024 | 10 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 8 | |
| 16 | 2018 | 5 | |
| 17 | 2025 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2020 | 1 |
About Arin Nam
Arin Nam is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Allergy and Immunology, having authored 22 papers that have together received 462 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers), Cell Adhesion Molecules Research (3 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Immunology and Allergy (46 citations), Cancer Research (102 citations), Oncology (134 citations), Molecular Biology (253 citations) and Pulmonary and Respiratory Medicine (94 citations). Arin Nam has collaborated with scholars based in United States, India and China. Frequent co-authors include Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, Atish Mohanty, Martin Sattler, Prakash Kulkarni, Erminia Massarelli, Saumya Srivastava, Sabrina Salgia and Sharad S. Singhal. Their work appears in journals such as iScience, Journal of Clinical Medicine, Oncotarget, Cancer Research and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.